✦ LIBER ✦

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia

✍ Scribed by Kami Maddocks-Christianson; Susan L. Slager; Clive S. Zent; Megan Reinalda; Timothy G. Call; Thomas M. Habermann; Deborah A. Bowen; James D. Hoyer; Susan Schwager; Diane F. Jelinek; Neil E. Kay; Tait D. Shanafelt

Book ID: 108675424
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 88 KB
Volume: 139
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2007.06801.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma as a source of mRNA for determini

Plasma as a source of mRNA for determining IgVH mutation status in patients with chronic lymphocytic leukaemia

✍ W. Ma; I. Jilani; M. Gorre; M. Keating; H. Chan; R. Tseng; H. Kantarjian; S. O'B 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Definition of progression risk based on

Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia

✍ Fortunato Morabito; Giovanna Cutrona; Massimo Gentile; Serena Matis; Katia Todoe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

Chronic lymphatic leukemia developing in

Chronic lymphatic leukemia developing in a patient with multiple myeloma. Immunologic demonstration of a clonally distinct second malignancy

✍ J. R. Zalcberg; F. N. Cornell; H. J. C. Ireton; K. M. McGrath; R. McLachlan; R. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 909 KB

Risk factors for developing a new venous

Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies

✍ M. A. SHAH; M. CAPANU; G. SOFF; T. ASMIS; D. P. KELSEN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Risk factors for development of hepatoce

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

✍ Masafumi Ikeda; Shigetoshi Fujiyama; Motohiko Tanaka; Michio Sata; Tatsuya Ide; 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 185 KB

Mitoxantrone in combination with an inhi

Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia

✍ Sarah L. Elliott; Clark Crawford; Evan Mulligan; Geoffrey Summerfield; Paula New 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB